Literature DB >> 10630507

Experimental colitis induced by trinitrobenzenesulfonic acid: an ultrastructural and histochemical study.

M I Torres1, M García-Martin, M I Fernández, N Nieto, A Gil, A Ríos.   

Abstract

Inflammatory bowel disease (IBD) of humans is a chronic and devastating disease of unknown etiology. Models of acute colitis in animals have been achieved by intrarectal administration of agents such as 2,4,6-trinitrobenzenesulfonic acid (TNBS) into rat colon. This agent induces focal inflammation and alterations in the colon with features similar to those found in chronic inflammatory diseases in humans. The aim of this study was to assess the effect of TNBS administration on histological and ultrastructural features of the rat colon, especially in areas not affected by transmural inflammation. Also in areas without transmural inflammation, we observed a significant increase in crypt diameter and in the number and area of the goblet cells, as well as alterations in the contents of mucin in goblet cells. We conclude that TNBS treatment in rats led to severe changes in normal architecture of the colon and also in damaged areas where no direct inflammation was produced.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10630507     DOI: 10.1023/a:1026651408998

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

1.  Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species.

Authors:  M B Grisham; C Volkmer; P Tso; T Yamada
Journal:  Gastroenterology       Date:  1991-08       Impact factor: 22.682

Review 2.  Mediators of inflammation in chronic inflammatory bowel disease.

Authors:  O H Nielsen; J Rask-Madsen
Journal:  Scand J Gastroenterol Suppl       Date:  1996

Review 3.  [Genetics of inflammatory bowel diseases].

Authors:  J P Hugot; P Laurent-Puig; G Thomas
Journal:  Gastroenterol Clin Biol       Date:  1995-11

4.  Computed tomography and granulocyte scintigraphy in active inflammatory bowel disease. Comparison with endoscopy and operative findings.

Authors:  J J Kolkman; T H Falke; J C Roos; D H Van Dijk; I M Bannink; W Den Hollander; M A Cuesta; A S Peña; S G Meuwissen
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

5.  Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease.

Authors:  J L Wallace; W K MacNaughton; G P Morris; P L Beck
Journal:  Gastroenterology       Date:  1989-01       Impact factor: 22.682

6.  Clinical patterns of familial inflammatory bowel disease.

Authors:  J Satsangi; C Grootscholten; H Holt; D P Jewell
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

7.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

8.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

Authors:  R Duchmann; I Kaiser; E Hermann; W Mayet; K Ewe; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

9.  Interleukin 8: cells of origin in inflammatory bowel disease.

Authors:  M C Grimm; S K Elsbury; P Pavli; W F Doe
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

10.  Involvement of interleukin-4 and -10 in inflammatory bowel disease.

Authors:  O H Nielsen; T Køppen; N Rüdiger; T Horn; J Eriksen; I Kirman
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

View more
  12 in total

1.  Structural and neuronal changes in rat ileum after ischemia with reperfusion.

Authors:  Lille-Mor Lindeström; Eva Ekblad
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

2.  Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis.

Authors:  Mahsa Moeinian; Seyedeh Farnaz Ghasemi-Niri; Shilan Mozaffari; Amir Hossein Abdolghaffari; Maryam Baeeri; Mona Navaea-Nigjeh; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 3.  Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy.

Authors:  M-I Torres; A Rios
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

4.  Proinflammatory and anti-inflammatory cytokines present in the acute phase of experimental colitis treated with Saccharomyces boulardii.

Authors:  Nathália Nahas Grijó; Ricardo Carneiro Borra; Vera Lucia Sdepanian
Journal:  Dig Dis Sci       Date:  2009-12-09       Impact factor: 3.199

5.  Isolation and Characterization of Putative Probiotic Bacterial Strain, Bacillus amyloliquefaciens, from North East Himalayan Soil Based on In Vitro and In Vivo Functional Properties.

Authors:  V I Hairul Islam; N Prakash Babu; P Pandikumar; S Ignacimuthu
Journal:  Probiotics Antimicrob Proteins       Date:  2011-12       Impact factor: 4.609

6.  Porcine ileitis model induced by TNBS-ethanol instillation.

Authors:  A M Merritt; C D Buergelt; L C Sanchez
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

7.  Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase.

Authors:  B J R Whittle; C Varga; A Berko; K Horvath; A Posa; J P Riley; K A Lundeen; A M Fourie; P J Dunford
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

8.  The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model.

Authors:  Antonio Ramón Martín; Isabel Villegas; Marina Sánchez-Hidalgo; Catalina Alarcón de la Lastra
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

9.  Preventive Therapy of Experimental Colitis with Selected iron Chelators and Anti-oxidants.

Authors:  Mohsen Minaiyan; Elahe Mostaghel; Parvin Mahzouni
Journal:  Int J Prev Med       Date:  2012-03

10.  Effects of extract and essential oil of Rosmarinus officinalis L. on TNBS-induced colitis in rats.

Authors:  M Minaiyan; A R Ghannadi; M Afsharipour; P Mahzouni
Journal:  Res Pharm Sci       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.